ASX - By Stock
|
SPL |
Re:
Ann: AZD0466 Clinical Data Presented by AstraZeneca EHA Congress
|
|
sarge17
|
79 |
18K |
0 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
79
|
18K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Genentech Agreements
|
|
sarge17
|
9 |
2.5K |
1 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
9
|
2.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma completes oversubscribed A$45M placement
|
|
sarge17
|
44 |
16K |
2 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
44
|
16K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Mirrabooka creeps up the list of top 20 holders in Starpharma
|
|
sarge17
|
43 |
13K |
1 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
43
|
13K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Is it finally time to buy???
|
|
sarge17
|
7 |
1.5K |
1 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
7
|
1.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Blackout Period
|
|
sarge17
|
24 |
4.5K |
3 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
24
|
4.5K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
sarge17
|
52 |
8.5K |
3 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
52
|
8.5K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
sarge17
|
52 |
8.5K |
2 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
52
|
8.5K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Genentech Agreements
|
|
sarge17
|
9 |
2.5K |
1 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
9
|
2.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Blackout Period
|
|
sarge17
|
24 |
4.5K |
3 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
24
|
4.5K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Can Starpharma mop up 10% of it's shares
|
|
sarge17
|
2 |
434 |
4 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
2
|
434
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
sarge17
|
52 |
8.5K |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
52
|
8.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
sarge17
|
52 |
8.5K |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
52
|
8.5K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
sarge17
|
52 |
8.5K |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
52
|
8.5K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
sarge17
|
52 |
8.5K |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
52
|
8.5K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
sarge17
|
52 |
8.5K |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
52
|
8.5K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
ASCO Presentations 2024
|
|
sarge17
|
29 |
5.6K |
0 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
29
|
5.6K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
ASCO Presentations 2024
|
|
sarge17
|
29 |
5.6K |
1 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
29
|
5.6K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
ASCO Presentations 2024
|
|
sarge17
|
29 |
5.6K |
2 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
29
|
5.6K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Medicxi and Starpharma.
|
|
sarge17
|
7 |
1.6K |
1 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
7
|
1.6K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
ASCO Presentations 2024
|
|
sarge17
|
29 |
5.6K |
1 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
29
|
5.6K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Is it finally time to cry?
|
|
sarge17
|
4 |
1.0K |
2 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
4
|
1.0K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Is it finally time to buy???
|
|
sarge17
|
7 |
1.5K |
0 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
7
|
1.5K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Is it finally time to cry?
|
|
sarge17
|
4 |
1.0K |
0 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
4
|
1.0K
|
0
|
|
ASX - By Stock
|
SPL |
Is it finally time to cry?
|
|
sarge17
|
4 |
1.0K |
1 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
4
|
1.0K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Is it finally time to buy???
|
|
sarge17
|
7 |
1.5K |
1 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
7
|
1.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
ASCO Presentations 2024
|
|
sarge17
|
29 |
5.6K |
0 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
29
|
5.6K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Blackout Period
|
|
sarge17
|
24 |
4.5K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
24
|
4.5K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Big Pharma or Vulture Capitalists
|
|
sarge17
|
11 |
2.2K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
11
|
2.2K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Medicxi and Starpharma.
|
|
sarge17
|
7 |
1.6K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
7
|
1.6K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Blackout Period
|
|
sarge17
|
24 |
4.5K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
24
|
4.5K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Medicxi and Starpharma.
|
|
sarge17
|
7 |
1.6K |
0 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
7
|
1.6K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Blackout Period
|
|
sarge17
|
24 |
4.5K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
24
|
4.5K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Blackout Period
|
|
sarge17
|
24 |
4.5K |
1 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
24
|
4.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
SPL chart
|
|
sarge17
|
451 |
139K |
0 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
451
|
139K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Fundamental Shafting
|
|
sarge17
|
6 |
1.6K |
3 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
6
|
1.6K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Could this happen to Viraleze with marketing approval
|
|
sarge17
|
29 |
5.3K |
0 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
29
|
5.3K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Could this happen to Viraleze with marketing approval
|
|
sarge17
|
29 |
5.3K |
1 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
29
|
5.3K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Could this happen to Viraleze with marketing approval
|
|
sarge17
|
29 |
5.3K |
2 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
29
|
5.3K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Could this happen to Viraleze with marketing approval
|
|
sarge17
|
29 |
5.3K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
29
|
5.3K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Genentech Agreements
|
|
sarge17
|
9 |
2.5K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
9
|
2.5K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Genentech Agreements
|
|
sarge17
|
9 |
2.5K |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
9
|
2.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Why no SPL announcement on TGA decison
|
|
sarge17
|
13 |
2.2K |
3 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
13
|
2.2K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - R Basser
|
|
sarge17
|
9 |
1.9K |
1 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
9
|
1.9K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - R Basser
|
|
sarge17
|
9 |
1.9K |
2 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
9
|
1.9K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Big Pharma or Vulture Capitalists
|
|
sarge17
|
11 |
2.2K |
2 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
11
|
2.2K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - R Thomas
|
|
sarge17
|
22 |
4.0K |
1 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
22
|
4.0K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - R Thomas
|
|
sarge17
|
22 |
4.0K |
1 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
22
|
4.0K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - R Thomas
|
|
sarge17
|
22 |
4.0K |
3 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
22
|
4.0K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - R Thomas
|
|
sarge17
|
22 |
4.0K |
3 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
22
|
4.0K
|
3
|
|